These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 11403060)

  • 21. Minocycline in amyotrophic lateral sclerosis: a pilot study.
    Pontieri FE; Ricci A; Pellicano C; Benincasa D; Buttarelli FR
    Neurol Sci; 2005 Oct; 26(4):285-7. PubMed ID: 16193258
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Motor neuron disease associated with multiple myeloma.
    Koc F; Paydas S; Yerdelen D; Demirkiran M
    Int J Neurosci; 2008 Mar; 118(3):337-41. PubMed ID: 18300006
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Access to palliative care for people with motor neurone disease in New Zealand: a patient's perspective.
    Williams B
    N Z Med J; 2005 Oct; 118(1224):U1711. PubMed ID: 16258583
    [No Abstract]   [Full Text] [Related]  

  • 24. Motor neurone disease - caring for the patient in general practice.
    Zoing M; Kiernan M
    Aust Fam Physician; 2011 Dec; 40(12):962-6. PubMed ID: 22146323
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rilutek should be subsidised.
    Smith W
    Nurs N Z; 2005 Oct; 11(9):4. PubMed ID: 16529266
    [No Abstract]   [Full Text] [Related]  

  • 26. Riluzole slows the progression of neuromuscular dysfunction in the wobbler mouse motor neuron disease.
    Ishiyama T; Okada R; Nishibe H; Mitsumoto H; Nakayama C
    Brain Res; 2004 Sep; 1019(1-2):226-36. PubMed ID: 15306257
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment approaches in motor neurone disease.
    Dharmadasa T; Matamala JM; Kiernan MC
    Curr Opin Neurol; 2016 Oct; 29(5):581-91. PubMed ID: 27454577
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of motor neurone disease.
    Howard RS; Orrell RW
    Postgrad Med J; 2002 Dec; 78(926):736-41. PubMed ID: 12509691
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Motor neuron disease.
    Jackson CE; Rosenfeld J
    Phys Med Rehabil Clin N Am; 2001 May; 12(2):335-52, ix-x. PubMed ID: 11345011
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacological treatment of ALS.
    Münch C; Ludolph AC
    Neurol Neurochir Pol; 2001; 35(1 Suppl):41-50. PubMed ID: 11732279
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multicenter clinical research networks for traumatic spinal cord injury: a critical pathway to discovery.
    Fehlings MG; Wilson JR
    J Neurosurg Spine; 2012 Sep; 17(1 Suppl):4-5; discussion 5. PubMed ID: 22985364
    [No Abstract]   [Full Text] [Related]  

  • 32. Is riluzole a potential therapy for Rett syndrome?
    Tsai SJ
    Med Hypotheses; 2015 Jul; 85(1):76-8. PubMed ID: 25858436
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Riluzole.
    Gelinas DF
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2000 Dec; 1 Suppl 4():3-4. PubMed ID: 11466957
    [No Abstract]   [Full Text] [Related]  

  • 34. [Tolerance of riluzole in a phase IIIb clinical trial].
    Lacomblez L; Dib M; Doppler V; Faudet A; Robin V; Salachas F; Bensimon G; Meininger V
    Therapie; 2002; 57(1):65-71. PubMed ID: 12090150
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Toward more efficient clinical trials for amyotrophic lateral sclerosis.
    Cudkowicz ME; Katz J; Moore DH; O'Neill G; Glass JD; Mitsumoto H; Appel S; Ravina B; Kieburtz K; Shoulson I; Kaufmann P; Khan J; Simpson E; Shefner J; Levin B; Cwik V; Schoenfeld D; Aggarwal S; McDermott MP; Miller RG
    Amyotroph Lateral Scler; 2010 May; 11(3):259-65. PubMed ID: 19961263
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Riluzole: a potential therapy for HIV dementia?
    McKinley GF
    Ann Pharmacother; 1999 Jan; 33(1):114-5. PubMed ID: 9972398
    [No Abstract]   [Full Text] [Related]  

  • 37. Neuroprotective effects of riluzole in Huntington's disease.
    Squitieri F; Ciammola A; Colonnese C; Ciarmiello A
    Eur J Nucl Med Mol Imaging; 2008 Jan; 35(1):221-2. PubMed ID: 17987289
    [No Abstract]   [Full Text] [Related]  

  • 38. Riluzole for levodopa-induced dyskinesias in advanced Parkinson's disease.
    Merims D; Ziv I; Djaldetti R; Melamed E
    Lancet; 1999 May; 353(9166):1764-5. PubMed ID: 10347995
    [No Abstract]   [Full Text] [Related]  

  • 39. Riluzole for the treatment of acute traumatic spinal cord injury: rationale for and design of the NACTN Phase I clinical trial.
    Fehlings MG; Wilson JR; Frankowski RF; Toups EG; Aarabi B; Harrop JS; Shaffrey CI; Harkema SJ; Guest JD; Tator CH; Burau KD; Johnson MW; Grossman RG
    J Neurosurg Spine; 2012 Sep; 17(1 Suppl):151-6. PubMed ID: 22985381
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Any placebo controlled trial of riluzole would surely be unethical now.
    Ford M; Leperlier C
    BMJ; 2001 Sep; 323(7312):573-4. PubMed ID: 11573491
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.